Facial Injectables Market By Product Type (Dermal Fillers, Botox), By End-user (Hospitals, Dermatology Centers, Physician's Office), By Region (North America, Europe, Asia Pacific, RoW) – Global Forecast up to 2025
Global Facial Injectables Market by Product Types (Dermal Fillers, Botox), By End-users (Hospitals, Dermatology Centers, Physician’s Office), and By Regions (North America, Europe, Asia Pacific, and Rest of the World) – Global Forecast up to 2025
This market research report includes a detailed segmentation of the global facial injectables market by product types (dermal fillers and Botox), by end-users (hospitals, dermatology centers, and physician’s office), and by regions (North America, Europe, APAC, and RoW).
Research Overview
Infoholic Research predicts that the global facial injectables market will grow at a CAGR of 10.81% during the forecast period 2019–2025. Facial injectables refer to the aesthetic treatment of the skin that results in a more youthful look. There are a variety of aesthetic procedures performed, including those used to treat skin conditions (deep lines & wrinkles), change the contours of jaw or lips, scars & depressions in the skin resulting from acne, congenital or injury imperfections, etc. Dermal fillers and Botox are the top-leading products used to treat these skin conditions. Dermal fillers offer treatment to face, neck, and hands, thereby resulting in a smooth, fuller, and more youthful look. Dermal fillers are increasingly being adopted due to immediate positive results, which have become popular globally. There are temporary fillers that are absorbed by the body and are classified into collagen-based fillers, hyaluronic acid-based fillers, calcium hydroxylapatite, and poly-L-lactic acid. These have provisional results and are used every 4–6 months. Permanent fillers are made of polymethylmethacrylate (PMMA), which are not absorbed by the body. ArteFill is among the most common brand used as permanent fillers.
An increase in beauty consciousness, growing awareness about facial injections, increasing demand for non-surgical & minimally invasive cosmetic surgeries, and anticipated launch of new products are expected to drive the market growth during the forecast period. The market is also witnessing few emerging trends, including increase in demand for combination treatments, rise in medical tourism, and increasing disposable income, which will drive the market at a significant pace during the forecast period. The facial injectables market in Brazil, India, China, and Russia is also expected to grow at a rapid pace during the forecast period as the adoption of cosmetic procedures in these countries is high.
Most of the vendors are focusing on evidence-based clinical results for the development and advancement of the product. The advancements in technology, the emergence of innovative products with the adoption of minimally invasive procedures, and the demand for facial injectables for the treatment of various skin conditions are driving the market growth.
The market is fueled by innovation and new technological techniques & procedures. The presence of large, small, and local vendors in the market has led to high competition among them. The global facial injectables market is dominated by Allergan, Galderma, Merz Pharma, and Ipsen. These vendors are consistently increasing their footprint in the market; regional vendors are finding it more difficult to compete with larger players, especially on quality, pricing, market reach, and financial resources. Further, they are expanding their inorganic growth by acquiring regional or local players.
Segmentation by Product Types:
Segmentation by End-users:
Segmentation by Regions:
The APAC region is expected to grow faster due to the increased adoption of dermal fillers. The growing number of facial aesthetic clinics offer immense opportunities for the market growth. HA dermal filler treatments, in particular, are gaining popularity in the fast-growing network of spas and beauty clinics in APAC. India and China are estimated to be the fastest-growing countries in this region. Dermal fillers are likely to show strong potential as consumers are moving toward using non-invasive and low-cost anti-aging aesthetic treatments.
Competitive Analysis – The competition among leading vendors is due to the availability of a wide range of facial injectables with different brand names in the market. This provides an opportunity for healthcare consumers to choose products based on brand, price, features, model, and discount. Most of the vendors are focusing on delivering bundling product models for increasing their sales and having a larger market share in terms of revenue. Many vendors have established their market presence globally and focus strongly on marketing and selling their products by competing with small and regional vendors. Therefore, the competition among the vendors is expected to hinder the market growth, yet the market will have more products developed and launched in the market. Most of the vendors are primarily focusing on R&D to offer fast technological progress. Manufacturers, including major and mid-sized companies, in the facial injectables market are competing with newer products, advanced features, quality, safety, and efficacy.
The competition is growing among the healthcare service providers – hospitals, dermatology centers, and physician’s offices where the customer groups are being consolidated for purchasing products. Diversified product portfolio companies, large volume product buyers (hospitals), and primary competitors (single product manufacturers) have strong market positions in certain segments and regions due to their wide range of products and services they offer. New competitors, especially from Asia, are also taking the competition to a new high with quality, safety, and efficacy of the product over the past few years.
Key Vendors:
Key Takeaways:
This market research report includes a detailed segmentation of the global facial injectables market by product types (dermal fillers and Botox), by end-users (hospitals, dermatology centers, and physician’s office), and by regions (North America, Europe, APAC, and RoW).
Research Overview
Infoholic Research predicts that the global facial injectables market will grow at a CAGR of 10.81% during the forecast period 2019–2025. Facial injectables refer to the aesthetic treatment of the skin that results in a more youthful look. There are a variety of aesthetic procedures performed, including those used to treat skin conditions (deep lines & wrinkles), change the contours of jaw or lips, scars & depressions in the skin resulting from acne, congenital or injury imperfections, etc. Dermal fillers and Botox are the top-leading products used to treat these skin conditions. Dermal fillers offer treatment to face, neck, and hands, thereby resulting in a smooth, fuller, and more youthful look. Dermal fillers are increasingly being adopted due to immediate positive results, which have become popular globally. There are temporary fillers that are absorbed by the body and are classified into collagen-based fillers, hyaluronic acid-based fillers, calcium hydroxylapatite, and poly-L-lactic acid. These have provisional results and are used every 4–6 months. Permanent fillers are made of polymethylmethacrylate (PMMA), which are not absorbed by the body. ArteFill is among the most common brand used as permanent fillers.
An increase in beauty consciousness, growing awareness about facial injections, increasing demand for non-surgical & minimally invasive cosmetic surgeries, and anticipated launch of new products are expected to drive the market growth during the forecast period. The market is also witnessing few emerging trends, including increase in demand for combination treatments, rise in medical tourism, and increasing disposable income, which will drive the market at a significant pace during the forecast period. The facial injectables market in Brazil, India, China, and Russia is also expected to grow at a rapid pace during the forecast period as the adoption of cosmetic procedures in these countries is high.
Most of the vendors are focusing on evidence-based clinical results for the development and advancement of the product. The advancements in technology, the emergence of innovative products with the adoption of minimally invasive procedures, and the demand for facial injectables for the treatment of various skin conditions are driving the market growth.
The market is fueled by innovation and new technological techniques & procedures. The presence of large, small, and local vendors in the market has led to high competition among them. The global facial injectables market is dominated by Allergan, Galderma, Merz Pharma, and Ipsen. These vendors are consistently increasing their footprint in the market; regional vendors are finding it more difficult to compete with larger players, especially on quality, pricing, market reach, and financial resources. Further, they are expanding their inorganic growth by acquiring regional or local players.
Segmentation by Product Types:
- Dermal Fillers
- Botox
Segmentation by End-users:
- Hospitals
- Dermatology Centers
- Physician’s Office
Segmentation by Regions:
- North America
- Europe
- Asia Pacific
- RoW
The APAC region is expected to grow faster due to the increased adoption of dermal fillers. The growing number of facial aesthetic clinics offer immense opportunities for the market growth. HA dermal filler treatments, in particular, are gaining popularity in the fast-growing network of spas and beauty clinics in APAC. India and China are estimated to be the fastest-growing countries in this region. Dermal fillers are likely to show strong potential as consumers are moving toward using non-invasive and low-cost anti-aging aesthetic treatments.
Competitive Analysis – The competition among leading vendors is due to the availability of a wide range of facial injectables with different brand names in the market. This provides an opportunity for healthcare consumers to choose products based on brand, price, features, model, and discount. Most of the vendors are focusing on delivering bundling product models for increasing their sales and having a larger market share in terms of revenue. Many vendors have established their market presence globally and focus strongly on marketing and selling their products by competing with small and regional vendors. Therefore, the competition among the vendors is expected to hinder the market growth, yet the market will have more products developed and launched in the market. Most of the vendors are primarily focusing on R&D to offer fast technological progress. Manufacturers, including major and mid-sized companies, in the facial injectables market are competing with newer products, advanced features, quality, safety, and efficacy.
The competition is growing among the healthcare service providers – hospitals, dermatology centers, and physician’s offices where the customer groups are being consolidated for purchasing products. Diversified product portfolio companies, large volume product buyers (hospitals), and primary competitors (single product manufacturers) have strong market positions in certain segments and regions due to their wide range of products and services they offer. New competitors, especially from Asia, are also taking the competition to a new high with quality, safety, and efficacy of the product over the past few years.
Key Vendors:
- Allergan plc
- Galderma
- Merz Pharma GmbH & Co. KGaA
- Ipsen S.A.
- The market is highly competitive, with all the players competing to gain the market share. Intense competition, rapid advancements in technology, frequent changes in government policies, and prices are the key factors that confront the market.
- The requirement of high initial investment, implementation, and maintenance cost in the market are also limiting the entry of new players.
- Responding to competitive pricing pressures specific to each of our geographic markets.
- Protection of proprietary technology for products and manufacturing processes.
Key Takeaways:
- Understanding the potential market opportunity with precise market size and forecast data.
- Detailed market analysis focusing on the growth of facial injectables in the aesthetic industry.
- Factors influencing the growth of the facial injectables market.
- In-depth competitive analysis of dominant and pureplay vendors.
- Prediction analysis of the facial injectables industry in both developed and developing regions.
- Key insights related to major segments of the facial injectables market.
- The latest market trend analysis impacting the buying behavior of the consumers.
1 INDUSTRY OUTLOOK
1.1 Medical Devices Industry
1.1.1 Overview
1.1.2 Facial Aesthetics
1.1.2.1 Facial Aesthetics
1.1.2.2 Botox
1.1.2.3 Dermal Fillers
1.1.2.4 Chemical Peel
1.1.2.5 Microdermabrasion
1.1.3 Materials Used in Soft Tissue Fillers
1.1.3.1 Absorbable Materials
1.1.3.2 Non-absorbable Materials
1.1.4 Industry Trends
1.2 Healthcare Spending
1.2.1 US
1.2.2 Europe
1.3 Regulatory Bodies & Standards
1.4 Emerging Global Markets
1.5 Patient Demographics
1.6 PESTLE Analysis
2 REPORT OUTLINE
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions
3 MARKET SNAPSHOT
3.1 Total Addressable Market
3.2 Segmented Addressable Market
3.3 Opportunity Analysis
3.4 Strategic Initiatives
3.5 Related Markets
3.5.1 Facial Aesthetics Market
3.5.2 Dental Implants Market
3.5.3 Breast Implant Market
3.5.4 Energy-based Aesthetic Devices Market
3.6 Porter 5 (Five) Forces
4 MARKET CHARACTERISTICS
4.1 Evolution
4.2 Market Dynamics
4.2.1 Drivers
4.2.1.1 Rise in focus on physical appearance to reverse the sign of aging
4.2.1.2 Rising geriatric population
4.2.1.3 Increased preference for minimally invasive cosmetic surgeries
4.2.1.4 Increasing awareness about anti-aging skincare measures
4.2.1.5 Increase in disposable income
4.2.2 Restraints
4.2.2.1 Complications and risks associated with facial injectables
4.2.2.2 High cost of facial injectables
4.2.2.3 Threat of counterfeit products in the market
4.2.2.4 Paucity of skilled professionals
4.2.2.1 Intense competition among vendors
4.2.3 Opportunities
4.2.3.1 Technological advancements
4.2.3.2 Upsurge in medical tourism
4.2.3.3 Increase in the demand for combination treatments
4.2.3.4 Increase in healthcare spending
4.2.4 DRO – Impact Analysis
4.3 Product Type Segmentation – Market Size and Forecast
4.3.1 Dermal Fillers
4.3.1.1 Overview
4.3.2 Featured Products
4.3.3 Botox
4.3.3.1 Overview
4.3.4 Featured Products
4.4 Key Stakeholders
5 END-USERS
5.1 Overview
5.2 Hospitals
5.3 Dermatology Centers
5.4 Physician’s Office
6 REGIONS
6.1 Overview
6.2 North America
6.2.1 Overview
6.2.2 Market Developments
6.3 Europe
6.3.1 Overview
6.3.2 Market Developments
6.4 APAC
6.4.1 Overview
6.4.2 Market Developments
6.5 Rest of the World
6.5.1 Overview
6.5.2 Market Developments
7 COMPETITIVE LANDSCAPE
7.1 Competitor Comparison Analysis
7.1.1 Competitiveness
7.1.2 Key Competitive Facts
8 VENDORS PROFILE
8.1 Allergan plc
8.1.1 Overview
8.1.2 Business Units
8.1.3 Business Focus
8.1.4 SWOT Analysis
8.1.5 Business Strategies
8.2 Galderma
8.2.1 Overview
8.2.2 Business Focus
8.2.3 SWOT Analysis
8.2.4 Business Strategies
8.3 Merz Pharma Gmbh & Co. KGaA
8.3.1 Overview
8.3.2 Geographic Presence
8.3.3 Business Focus
8.3.4 SWOT Analysis
8.3.5 Business Strategies
8.4 Ipsen S.A.
8.4.1 Overview
8.4.2 Business Units
8.4.3 Geographic Presence
8.4.4 Business Focus
8.4.5 SWOT Analysis
8.4.6 Business Strategies
9 COMPANIES TO WATCH FOR
9.1 Sinclair Pharma Plc
9.1.1 Overview
9.1.2 Business Strategies
9.2 Bloomage BioTechology Corp. Ltd.
9.2.1 Overview
9.2.2 Key Highlights
9.2.3 Business Strategies
9.3 Bausch Health Companies Inc. (formerly Valeant Pharmaceuticals International Inc)
9.3.1 Overview
9.3.2 Key Highlights
9.3.3 Business Strategies
10 OTHER PROMINENT VENDORS
11 ANNEXURE
1.1 Medical Devices Industry
1.1.1 Overview
1.1.2 Facial Aesthetics
1.1.2.1 Facial Aesthetics
1.1.2.2 Botox
1.1.2.3 Dermal Fillers
1.1.2.4 Chemical Peel
1.1.2.5 Microdermabrasion
1.1.3 Materials Used in Soft Tissue Fillers
1.1.3.1 Absorbable Materials
1.1.3.2 Non-absorbable Materials
1.1.4 Industry Trends
1.2 Healthcare Spending
1.2.1 US
1.2.2 Europe
1.3 Regulatory Bodies & Standards
1.4 Emerging Global Markets
1.5 Patient Demographics
1.6 PESTLE Analysis
2 REPORT OUTLINE
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions
3 MARKET SNAPSHOT
3.1 Total Addressable Market
3.2 Segmented Addressable Market
3.3 Opportunity Analysis
3.4 Strategic Initiatives
3.5 Related Markets
3.5.1 Facial Aesthetics Market
3.5.2 Dental Implants Market
3.5.3 Breast Implant Market
3.5.4 Energy-based Aesthetic Devices Market
3.6 Porter 5 (Five) Forces
4 MARKET CHARACTERISTICS
4.1 Evolution
4.2 Market Dynamics
4.2.1 Drivers
4.2.1.1 Rise in focus on physical appearance to reverse the sign of aging
4.2.1.2 Rising geriatric population
4.2.1.3 Increased preference for minimally invasive cosmetic surgeries
4.2.1.4 Increasing awareness about anti-aging skincare measures
4.2.1.5 Increase in disposable income
4.2.2 Restraints
4.2.2.1 Complications and risks associated with facial injectables
4.2.2.2 High cost of facial injectables
4.2.2.3 Threat of counterfeit products in the market
4.2.2.4 Paucity of skilled professionals
4.2.2.1 Intense competition among vendors
4.2.3 Opportunities
4.2.3.1 Technological advancements
4.2.3.2 Upsurge in medical tourism
4.2.3.3 Increase in the demand for combination treatments
4.2.3.4 Increase in healthcare spending
4.2.4 DRO – Impact Analysis
4.3 Product Type Segmentation – Market Size and Forecast
4.3.1 Dermal Fillers
4.3.1.1 Overview
4.3.2 Featured Products
4.3.3 Botox
4.3.3.1 Overview
4.3.4 Featured Products
4.4 Key Stakeholders
5 END-USERS
5.1 Overview
5.2 Hospitals
5.3 Dermatology Centers
5.4 Physician’s Office
6 REGIONS
6.1 Overview
6.2 North America
6.2.1 Overview
6.2.2 Market Developments
6.3 Europe
6.3.1 Overview
6.3.2 Market Developments
6.4 APAC
6.4.1 Overview
6.4.2 Market Developments
6.5 Rest of the World
6.5.1 Overview
6.5.2 Market Developments
7 COMPETITIVE LANDSCAPE
7.1 Competitor Comparison Analysis
7.1.1 Competitiveness
7.1.2 Key Competitive Facts
8 VENDORS PROFILE
8.1 Allergan plc
8.1.1 Overview
8.1.2 Business Units
8.1.3 Business Focus
8.1.4 SWOT Analysis
8.1.5 Business Strategies
8.2 Galderma
8.2.1 Overview
8.2.2 Business Focus
8.2.3 SWOT Analysis
8.2.4 Business Strategies
8.3 Merz Pharma Gmbh & Co. KGaA
8.3.1 Overview
8.3.2 Geographic Presence
8.3.3 Business Focus
8.3.4 SWOT Analysis
8.3.5 Business Strategies
8.4 Ipsen S.A.
8.4.1 Overview
8.4.2 Business Units
8.4.3 Geographic Presence
8.4.4 Business Focus
8.4.5 SWOT Analysis
8.4.6 Business Strategies
9 COMPANIES TO WATCH FOR
9.1 Sinclair Pharma Plc
9.1.1 Overview
9.1.2 Business Strategies
9.2 Bloomage BioTechology Corp. Ltd.
9.2.1 Overview
9.2.2 Key Highlights
9.2.3 Business Strategies
9.3 Bausch Health Companies Inc. (formerly Valeant Pharmaceuticals International Inc)
9.3.1 Overview
9.3.2 Key Highlights
9.3.3 Business Strategies
10 OTHER PROMINENT VENDORS
11 ANNEXURE
LIST OF TABLES
TABLE 1 MEDICAL DEVICES BY CATEGORY
TABLE 2 TOP LISTED MEDICAL DEVICES COMPANY IN 2018
TABLE 3 FACIAL INJECTABLES MARKET OUTLOOK
TABLE 4 AVERAGE COST OF DERMAL FACIAL FILLERS
TABLE 5 DRO OF DERMAL FILLERS MARKET
TABLE 6 DRO OF BOTOX MARKET
TABLE 7 GLOBAL FACIAL INJECTABLES MARKET BY END-USERS
TABLE 8 GLOBAL FACIAL INJECTABLES REVENUE BY REGIONS, 2019–2025 ($MILLION)
TABLE 9 DRO (NORTH AMERICA)
TABLE 10 DRO (EUROPE)
TABLE 11 DRO (APAC)
TABLE 12 DRO (REST OF THE WORLD)
TABLE 13 COMPETITIVE STRUCTURE ANALYSIS OF GLOBAL FACIAL INJECTABLES MARKET (2018)
TABLE 14 ALLERGAN PLC: PRODUCT OFFERINGS
TABLE 15 ALLERGAN PLC: RECENT DEVELOPMENTS
TABLE 16 GALDERMA: PRODUCT OFFERINGS
TABLE 17 GALDERMA: RECENT DEVELOPMENTS
TABLE 18 MERZ PHARMA GMBH & CO. KGAA: PRODUCT OFFERINGS
TABLE 19 MERZ PHARMA GMBH & CO. KGAA: RECENT DEVELOPMENTS
TABLE 20 IPSEN S.A.: PRODUCT OFFERINGS
TABLE 21 IPSEN S.A.: RECENT DEVELOPMENTS
TABLE 22 SINCLAIR PHARMA PLC: SNAPSHOT
TABLE 23 SINCLAIR PHARMA PLC: RECENT DEVELOPMENTS
TABLE 24 BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED: SNAPSHOT
TABLE 25 BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED: RECENT DEVELOPMENTS
TABLE 26 VALEANT PHARMACEUTICALS INTERNATIONAL INC: SNAPSHOT
TABLE 27 VALEANT PHARMACEUTICALS INTERNATIONAL, INC.: RECENT DEVELOPMENTS
TABLE 28 OTHER PROMINENT VENDORS IN THE GLOBAL FACIAL INJECTABLES MARKET
TABLE 1 MEDICAL DEVICES BY CATEGORY
TABLE 2 TOP LISTED MEDICAL DEVICES COMPANY IN 2018
TABLE 3 FACIAL INJECTABLES MARKET OUTLOOK
TABLE 4 AVERAGE COST OF DERMAL FACIAL FILLERS
TABLE 5 DRO OF DERMAL FILLERS MARKET
TABLE 6 DRO OF BOTOX MARKET
TABLE 7 GLOBAL FACIAL INJECTABLES MARKET BY END-USERS
TABLE 8 GLOBAL FACIAL INJECTABLES REVENUE BY REGIONS, 2019–2025 ($MILLION)
TABLE 9 DRO (NORTH AMERICA)
TABLE 10 DRO (EUROPE)
TABLE 11 DRO (APAC)
TABLE 12 DRO (REST OF THE WORLD)
TABLE 13 COMPETITIVE STRUCTURE ANALYSIS OF GLOBAL FACIAL INJECTABLES MARKET (2018)
TABLE 14 ALLERGAN PLC: PRODUCT OFFERINGS
TABLE 15 ALLERGAN PLC: RECENT DEVELOPMENTS
TABLE 16 GALDERMA: PRODUCT OFFERINGS
TABLE 17 GALDERMA: RECENT DEVELOPMENTS
TABLE 18 MERZ PHARMA GMBH & CO. KGAA: PRODUCT OFFERINGS
TABLE 19 MERZ PHARMA GMBH & CO. KGAA: RECENT DEVELOPMENTS
TABLE 20 IPSEN S.A.: PRODUCT OFFERINGS
TABLE 21 IPSEN S.A.: RECENT DEVELOPMENTS
TABLE 22 SINCLAIR PHARMA PLC: SNAPSHOT
TABLE 23 SINCLAIR PHARMA PLC: RECENT DEVELOPMENTS
TABLE 24 BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED: SNAPSHOT
TABLE 25 BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED: RECENT DEVELOPMENTS
TABLE 26 VALEANT PHARMACEUTICALS INTERNATIONAL INC: SNAPSHOT
TABLE 27 VALEANT PHARMACEUTICALS INTERNATIONAL, INC.: RECENT DEVELOPMENTS
TABLE 28 OTHER PROMINENT VENDORS IN THE GLOBAL FACIAL INJECTABLES MARKET
LIST OF FIGURES
CHART 1 GLOBAL MEDICAL DEVICE MARKET BY GEOGRAPHY (2018)
CHART 2 GLOBAL MEDICAL DEVICES MARKET SEGMENTATION
CHART 3 FACIAL INJECTABLES SEGMENTATION BY AESTHETICS TYPES
CHART 4 MATERIALS USED IN SOFT TISSUE FILLERS
CHART 5 GLOBAL AESTHETIC SURGICAL AND NON-SURGICAL PROCEDURES, 2017
CHART 6 NUMBER OF AESTHETIC PROCEDURES PERFORMED IN THE US IN 2018 (MILLION)
CHART 7 PERCENTAGE OF AESTHETIC PROCEDURES PERFORMED IN THE US IN 2017 (%)
CHART 8 TOP FIVE NON-SURGICAL PROCEDURES IN 2018 (WORLDWIDE)
CHART 9 IMPERATIVES OF EMERGING MARKETS
CHART 10 WORLD POPULATION AGED 65 YEARS AND ABOVE, 1960–2060 (%)
CHART 11 PESTLE ANALYSIS OF FACIAL INJECTABLES MARKET
CHART 12 RESEARCH METHODOLOGY OF GLOBAL FACIAL INJECTABLES MARKET
CHART 13 GLOBAL MEDICAL AESTEHTIC MARKET OVERVIEW
CHART 14 GLOBAL FACIAL INJECTABLES MARKET REVENUE, 2018–2025 ($MILLION)
CHART 15 OPPORTUNITY ANALYSIS
CHART 16 PORTERS 5 FORCES ON GLOBAL FACIAL INJUECTABLES MARKET
CHART 17 FILLER MARKET EVOLUTION IN THE US
CHART 18 MARKET DYNAMICS – DRIVERS, RESTRAINTS & OPPORTUNITIES
CHART 19 DRO - IMPACT ANALYSIS OF GLOBAL FACIAL INJECTABLES MARKET
CHART 20 GLOBAL FACIAL INJECTABLES MARKET SEGMENTATION
CHART 21 GLOBAL FACIAL INJECTABLES MARKET 2018
CHART 22 GLOBAL FACIAL INJECTABLES MARKET OVERVIEW BY PRODUCTS 2018 ($MILLION)
CHART 23 GLOBAL FACIAL INJECTABLES MARKET SEGMENTATION BY PRODUCT, 2018–2025 ($MILLION)
CHART 24 GLOBAL FACIAL INJECTABLES MARKET SEGMENTATION BY PRODUCT, 2018–2025 (%)
CHART 25 GLOBAL DERMAL FILLERS MARKET BY REVENUE, 2018–2025 ($MILLION)
CHART 26 GLOBAL BOTOX MARKET REVENUE, 2018–2025 ($MILLION)
CHART 27 KEY STAKEHOLDERS OF GLOBAL FACIAL INJECTABLES MARKET
CHART 28 GLOBAL FACIAL INJECTABLES MARKET BY END-USER SEGMENTATION, 2018 (%)
CHART 29 BUYING CRITERIA
CHART 30 GLOBAL FACIAL INJECTABLES MARKET BY GEOGRAPHICAL SEGMENTATION, 2018 AND 2025 (%)
CHART 31 GLOBAL FACIAL INJECTABLES MARKET BY REGIONS 2018 ($MILLION)
CHART 32 FACIAL INJECTABLES MARKET REVENUE IN NORTH AMERICA, 2018–2025 ($MILLION)
CHART 33 FACIAL INJECTABLES MARKET REVENUE IN EUROPE, 2018–2025 ($MILLION)
CHART 34 FACIAL INJECTABLES MARKET REVENUE IN APAC, 2018–2025 ($MILLION)
CHART 35 FACIAL INJECTABLES MARKET REVENUE FORECAST IN REST OF THE WORLD, 2018–2025 ($MILLION)
CHART 36 GLOBAL FACIAL INJECTABLES MARKET SEGMENTATION BY GEOGRAPHY, 2018–2025 ($MILLION)
CHART 37 GLOBAL FACIAL INJETCABLES MARKET SEGMENTATION BY GEOGRAPHY, 2018–2025 (%)
CHART 38 ALLERGAN PLC: OVERVIEW SNAPSHOT
CHART 39 ALLERGAN PLC: BUSINESS UNITS
CHART 40 ALLERGAN PLC: SWOT ANALYSIS
CHART 41 GALDERMA : SWOT ANALYSIS
CHART 42 MERZ PHARMA GMBH & CO. KGAA: OVERVIEW SNAPSHOT
CHART 43 MERZ PHARMA GMBH & CO. KGAA: GEOGRAPHIC PRESENCE
CHART 44 MERZ PHARMA GMBH & CO. KGAA: SWOT ANALYSIS
CHART 45 IPSEN S.A.: OVERVIEW SNAPSHOT
CHART 46 IPSEN S.A.: BUSINESS UNITS
CHART 47 IPSEN S.A.: GEOGRAPHIC PRESENCE
CHART 48 IPSEN S.A.: SWOT ANALYSIS
COMPANIES MENTIONED
Allergan plc
Galderma
Merz Pharma GmbH & Co. KGaA
Ipsen S.A.
CHART 1 GLOBAL MEDICAL DEVICE MARKET BY GEOGRAPHY (2018)
CHART 2 GLOBAL MEDICAL DEVICES MARKET SEGMENTATION
CHART 3 FACIAL INJECTABLES SEGMENTATION BY AESTHETICS TYPES
CHART 4 MATERIALS USED IN SOFT TISSUE FILLERS
CHART 5 GLOBAL AESTHETIC SURGICAL AND NON-SURGICAL PROCEDURES, 2017
CHART 6 NUMBER OF AESTHETIC PROCEDURES PERFORMED IN THE US IN 2018 (MILLION)
CHART 7 PERCENTAGE OF AESTHETIC PROCEDURES PERFORMED IN THE US IN 2017 (%)
CHART 8 TOP FIVE NON-SURGICAL PROCEDURES IN 2018 (WORLDWIDE)
CHART 9 IMPERATIVES OF EMERGING MARKETS
CHART 10 WORLD POPULATION AGED 65 YEARS AND ABOVE, 1960–2060 (%)
CHART 11 PESTLE ANALYSIS OF FACIAL INJECTABLES MARKET
CHART 12 RESEARCH METHODOLOGY OF GLOBAL FACIAL INJECTABLES MARKET
CHART 13 GLOBAL MEDICAL AESTEHTIC MARKET OVERVIEW
CHART 14 GLOBAL FACIAL INJECTABLES MARKET REVENUE, 2018–2025 ($MILLION)
CHART 15 OPPORTUNITY ANALYSIS
CHART 16 PORTERS 5 FORCES ON GLOBAL FACIAL INJUECTABLES MARKET
CHART 17 FILLER MARKET EVOLUTION IN THE US
CHART 18 MARKET DYNAMICS – DRIVERS, RESTRAINTS & OPPORTUNITIES
CHART 19 DRO - IMPACT ANALYSIS OF GLOBAL FACIAL INJECTABLES MARKET
CHART 20 GLOBAL FACIAL INJECTABLES MARKET SEGMENTATION
CHART 21 GLOBAL FACIAL INJECTABLES MARKET 2018
CHART 22 GLOBAL FACIAL INJECTABLES MARKET OVERVIEW BY PRODUCTS 2018 ($MILLION)
CHART 23 GLOBAL FACIAL INJECTABLES MARKET SEGMENTATION BY PRODUCT, 2018–2025 ($MILLION)
CHART 24 GLOBAL FACIAL INJECTABLES MARKET SEGMENTATION BY PRODUCT, 2018–2025 (%)
CHART 25 GLOBAL DERMAL FILLERS MARKET BY REVENUE, 2018–2025 ($MILLION)
CHART 26 GLOBAL BOTOX MARKET REVENUE, 2018–2025 ($MILLION)
CHART 27 KEY STAKEHOLDERS OF GLOBAL FACIAL INJECTABLES MARKET
CHART 28 GLOBAL FACIAL INJECTABLES MARKET BY END-USER SEGMENTATION, 2018 (%)
CHART 29 BUYING CRITERIA
CHART 30 GLOBAL FACIAL INJECTABLES MARKET BY GEOGRAPHICAL SEGMENTATION, 2018 AND 2025 (%)
CHART 31 GLOBAL FACIAL INJECTABLES MARKET BY REGIONS 2018 ($MILLION)
CHART 32 FACIAL INJECTABLES MARKET REVENUE IN NORTH AMERICA, 2018–2025 ($MILLION)
CHART 33 FACIAL INJECTABLES MARKET REVENUE IN EUROPE, 2018–2025 ($MILLION)
CHART 34 FACIAL INJECTABLES MARKET REVENUE IN APAC, 2018–2025 ($MILLION)
CHART 35 FACIAL INJECTABLES MARKET REVENUE FORECAST IN REST OF THE WORLD, 2018–2025 ($MILLION)
CHART 36 GLOBAL FACIAL INJECTABLES MARKET SEGMENTATION BY GEOGRAPHY, 2018–2025 ($MILLION)
CHART 37 GLOBAL FACIAL INJETCABLES MARKET SEGMENTATION BY GEOGRAPHY, 2018–2025 (%)
CHART 38 ALLERGAN PLC: OVERVIEW SNAPSHOT
CHART 39 ALLERGAN PLC: BUSINESS UNITS
CHART 40 ALLERGAN PLC: SWOT ANALYSIS
CHART 41 GALDERMA : SWOT ANALYSIS
CHART 42 MERZ PHARMA GMBH & CO. KGAA: OVERVIEW SNAPSHOT
CHART 43 MERZ PHARMA GMBH & CO. KGAA: GEOGRAPHIC PRESENCE
CHART 44 MERZ PHARMA GMBH & CO. KGAA: SWOT ANALYSIS
CHART 45 IPSEN S.A.: OVERVIEW SNAPSHOT
CHART 46 IPSEN S.A.: BUSINESS UNITS
CHART 47 IPSEN S.A.: GEOGRAPHIC PRESENCE
CHART 48 IPSEN S.A.: SWOT ANALYSIS
COMPANIES MENTIONED
Allergan plc
Galderma
Merz Pharma GmbH & Co. KGaA
Ipsen S.A.
